♫musicjinni

2023 Notable Articles | New England Journal of Medicine

video thumbnail
Eric J. Rubin, M.D., Ph.D., Editor-in-Chief of the _New England Journal of Medicine_, previews the Notable Articles of 2023, a collection of article abstracts, Research Summaries, and accompanying Editorials from the selected studies.

Featured studies include:
• Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
• Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
• Lecanemab in Early Alzheimer's Disease
• Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage Trial
• Treatment Strategy for Rifampin-Susceptible Tuberculosis
• Bonus notable articles from NEJM Catalyst Innovations in Care Delivery, NEJM Evidence, and the new NEJM Group journal – NEJM AI

Download the 13 articles NEJM editors selected as the most meaningful in changing clinical practice and improving patient care in 2023: https://nej.md/479vbyr

#medicalresearch #clinicaltrials #NEJM #medicalscience

2023 Notable Articles | New England Journal of Medicine

Getting Better: 200 Years of Medicine | NEJM

Medical Mystery Solved – A Deficient Diagnosis | NEJM

Medical Mystery Solved — Hunting for a Diagnosis | NEJM

Medical Mystery Solved – A Treacherous Course | NEJM

Medical Mystery Solved — Hard to Swallow | NEJM

Welcome Video from the Editors of NEJM Evidence

NEJM Knowledge+ Internal Medicine Board Review Demo

Depression (Episode 1 of 4) — Understanding, Identifying, and Diagnosing | NEJM

The Country Doctor in the Age of Corporate Medicine | NEJM

Explore the features of NEJM.org

What Is Rheumatoid Arthritis? | NEJM

Preoxygenation with Noninvasive Ventilation | NEJM

Monoclonal Antibody to Prevent Malaria | NEJM

Andexanet for FXa Inhibitor–Associated Acute ICH | NEJM

Trailer: NEJM Group Presents Intention to Treat

The Case of the Missing Data | NEJM Evidence

Semaglutide and Cardiovascular Outcomes in Obesity | NEJM

Alzheimer’s Disease — Anti-Amyloid Medications, Early Detection, and Screening | NEJM

Glycemia Reduction Approaches in Type 2 Diabetes | NEJM

Resmetirom for NASH with Liver Fibrosis | NEJM

DAPT up to 72 Hours after Ischemic Stroke | NEJM

Ketamine vs. ECT for Major Depression | NEJM

Tickborne Diseases | NEJM

Welcome from the Editors of NEJM AI

Anticoagulation Timing after Stroke in Atrial Fibrillation | NEJM

Alzheimer’s Disease — Managing Stages of Dementia | NEJM

Weight and Health – Supporting Patients (Chapter 2 of 3) | NEJM

Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Cancer | NEJM

TAVI or SAVR for Aortic-Valve Stenosis | NEJM

Disclaimer DMCA